Roll of Nitrous Oxide (NO) and Cyclic GMP in Cancer

一氧化二氮 (NO) 和环 GMP 在癌症中的作用

基本信息

批准号：
10256298
负责人：
FERID MURAD
金额：
--
依托单位：
VETERANS ADMIN PALO ALTO HEALTH CARE SYS
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-10-01 至 2025-09-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10256298
关键词：
Affect American Aneuploidy Animals Apoptosis Basement membrane Biological Biological Models Breast Cancer Patient Breast Cancer cell line Breast cancer metastasis Cancer Control Cancer cell line Cardiovascular system Categories Cell Nucleus Cells Cyclic GMP Cyclin-Dependent Kinases DNA Repair Data Deterioration Diagnosis Distant Distant Metastasis Elements Endothelium Enzymes Epithelial Cells Extracellular Matrix G1 Phase Gene Expression Glioma Goals HDAC3 gene Histone Deacetylase Human Immune Immune System Diseases Immunologic Surveillance Immunological Models Implant Individual Invaded Malignant Neoplasms Mediating Metastatic breast cancer Military Personnel Modeling Mus Neoplasm Circulating Cells Neoplasm Metastasis Nitric Oxide Nitrous Oxide Nuclear Translocation Organ Pathway interactions Patients Pharmacology Positioning Attribute Primary Neoplasm Production Proliferating Receptor Signaling Recurrence Role Signal Pathway Signal Transduction Signaling Molecule Signaling Protein Site Soluble Guanylate Cyclase Stromal Cells Surface TP53 gene Testing Therapeutic Time Tissues Tumor Suppression Tumor Suppressor Proteins Tumor-associated macrophages Vascular Endothelial Cell Woman active duty angiogenesis antagonist base cancer cell cancer initiation cancer recurrence cancer therapy drug discovery genome-wide human tissue innovation malignant breast neoplasm neoplastic cell novel novel therapeutic intervention response triple-negative invasive breast carcinoma tumor

项目摘要

This project focuses on the problem of breast cancer metastasis and recurrence, and on a novel signaling pathway that is positioned to modulate both. The key signaling molecule is the β1 subunit of soluble guanylate cyclase (sGC), an enzyme that normally functions as a heterodimer composed of α1 and β1 subunits (termed here sGCα1 and sGCβ1). In biological models, sGCβ1, but not sGCα1, can translocate into the nucleus, where it regulates expression of p53 and specific cyclin dependent protein kinases and induces G0/G1 phase arrest. Moreover sGCβ1, but not sGCα1, markedly inhibits proliferation and colony formation of human cancer cell lines, and lengthens survival time of orthotropic implanted mice over control. In human breast cancer patients, levels of sGCβ1 (but not sGCα1) directly correlate with patient survival in authentic breast cancer patients (n =1664). The hypothesis that altered expression of sGCβ1 in tumor stroma (including epithelial cells, immune cells, and vascular endothelial cells) alters responses to niche signals and modulates breast cancer recurrence will be tested by (1) interrogating the effects of sGCβ1 expression on circulating tumor cell (CTC) cluster formation, (2) examining the role of sGCβ1 expression in modulating breast cancer recurrence arising from angiogenic dormancy, and (3) determining the ability of sGCβ1-targeted histone deacetylase signaling to reverse immune dysfunction. Successfully completed, this project will validate the importance of sGCβ1-targeted HDAC signaling against recurrence of dormant breast cancer, and point the field toward new therapeutic strategies for treating metastatic breast cancer.

该项目重点关注乳腺癌转移和复发的问题，以及一种新的信号传导调节两者的关键信号分子是可溶性鸟苷酸的 β1 亚基。环化酶 (sGC)，一种通常作为由 α1 和 β1 亚基组成的异二聚体发挥作用的酶（称为这里是 sGCα1 和 sGCβ1），在生物模型中，sGCβ1（但不是 sGCα1）可以转位到细胞核中，其中它调节 p53 和特定细胞周期蛋白依赖性蛋白激酶的表达并诱导 G0/G1 期停滞。此外，sGCβ1（而非 sGCα1）显着抑制人类癌细胞系的增殖和集落形成，与对照相比，正交异性植入小鼠的存活时间更长。 sGCβ1（但不是 sGCα1）的含量与真实乳腺癌患者的生存率直接相关 (n = 1664)。改变肿瘤基质（包括上皮细胞、免疫细胞和肿瘤细胞）中 sGCβ1 表达的假说血管内皮细胞）改变对生态位信号的反应并调节乳腺癌复发通过 (1) 探讨 sGCβ1 表达对循环肿瘤细胞 (CTC) 簇形成的影响进行测试，(2) 检查 sGCβ1 表达在调节血管生成引起的乳腺癌复发中的作用休眠，以及 (3) 确定 sGCβ1 靶向组蛋白脱乙酰酶信号传导逆转免疫的能力该项目成功完成后，将验证 sGCβ1 靶向 HDAC 信号传导的重要性。对抗休眠乳腺癌的复发，并为治疗指明了新的治疗策略转移性乳腺癌。